Healthcare Strategy Partners (HSP)

What Healthcare Strategy Partners (HSP) does

Healthcare Strategy Partners (HSP) is a Boston-headquartered healthcare consulting firm founded in 2018 that provides evidence-based strategic consulting, quantitative and qualitative market research, and advanced data analytics exclusively to the BioPharma industry. The firm operates three integrated service lines — Evidence-Based Consulting, Strategic Market Research, and Data Structuring & Analysis — covering the full product lifecycle from molecule to generic, with use cases spanning commercial due diligence, indication prioritization, portfolio and brand strategy, product launch communications, segmentation, demand modeling, and value demonstration.

HSP's technical approach combines proprietary analytical frameworks — including Holistic Simultaneous Modeling for Segmentation, a Product Demand Modeling Framework, Smart ATUs (Awareness, Trial, Usage studies), and Sophisticated Choice Modeling — with integration of primary survey research and secondary healthcare data sources (claims, prescription, EMR, insurance, social media). A four-person senior leadership team, with prior tenure at IQVIA, McKinsey, ZS Associates, Quintiles, and MedPanel, delivers engagements personally and is positioned as the firm's core differentiator versus larger competitors.

HSP generates revenue through project-based professional services engagements sold via direct enterprise relationships with pharmaceutical and biotech clients. Pricing is quote-based and not publicly disclosed. The firm maintains offices in Boston, Princeton, and Washington, DC to serve enterprise biopharma buyers across the US East Coast, with stated global engagement capability. No external funding rounds, parent company, or M&A activity have been disclosed.

Name

Healthcare Strategy Partners (HSP)

Legal name

Healthcare Strategy Partners

Website

https://hcstrategypartners.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Healthcare Strategy Partners is a boutique biopharma consulting firm offering evidence-based strategy consulting, quantitative market research, and advanced data analytics to pharmaceutical and biotech clients across the product lifecycle.

Ownership category

akta.pro rank

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Strategic Consulting Engagements: HSP generates revenue through project-based consulting engagements covering investment decisions, portfolio/brand strategy, launch communications, and value demonstrations for BioPharma companies. Engagements are designed, executed, and delivered by the senior team.
2. Market Research Services: Quantitative and qualitative market research services exclusively for the BioPharma industry, including segmentation, product launch communications, product demand modeling, ATUs, patient journey research, and rescue/remediation studies.
3. Data Structuring and Analysis Services: Expert evidence-based strategy and solutions based on comprehensive secondary data resources, including objective sourcing, strategic problem-solving, extensive data integration, and advanced analytics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

HSP provides evidence-based strategic consulting exclusively for the BioPharma industry, with three integrated service lines: Evidence-Based Strategy Consulting (investment decisions, portfolio/brand strategy, launch communications, value demonstrations), Strategic Market Research (segmentation, demand modeling, ATUs, patient journey research, remediation studies), and Data Structuring & Analysis (integration of primary survey data with secondary sources such as claims, prescription, EMR, and insurance data). Engagements are senior-led and supported by proprietary modeling tools including Holistic Simultaneous Modeling, Smart ATUs, and Sophisticated Choice Modeling.

Product overview

HSP is a healthcare consulting firm offering three interconnected service lines for the BioPharma industry: Evidence-Based Strategy Consulting (investment decisions, portfolio/brand strategy, launch communications, value demonstrations), Strategic Market Research (segmentation, demand modeling, launch communications, patient journey), and Data Structuring & Analysis (primary/secondary data integration, analytics). The services are designed to work together holistically, with data analysis supporting strategic consulting engagements and market research providing insights across the product lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• Evidence-Based Strategy Consulting Strategic consulting services for BioPharma clients covering investment decisions, portfolio and brand strategy, launch communications, and value demonstrations, integrating clinical development, medical, digital health, and market access expertise.
• Strategic Market Research
• Data Structuring & Analysis

Named customers2 records

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• ClearView Healthcare Partners: Boutique strategy consulting firm focused exclusively on the biopharmaceutical industry, with services spanning commercial due diligence, brand strategy, and launch planning. Most analogous to HSP in size, exclusivity, and senior-led engagement model.
• Putnam Associates: Specialist strategy consulting firm dedicated to biopharma and life sciences, with services spanning commercial strategy, portfolio prioritization, and launch planning. Closely comparable to HSP in scope, exclusivity, and boutique positioning.
• Charles River Associates (CRA): Global consulting firm with a Life Sciences practice providing commercial strategy, litigation support, and analytics to pharma and biotech clients. Competes with HSP on commercial due diligence and biopharma strategy engagements.
• ZS Associates: Global consulting firm with a deeply specialized pharma and biotech practice covering strategy, market research, sales, and analytics. Head of Strategic Consulting Ritesh Kumar previously led at ZS, and the two firms compete for the same commercial strategy and analytics engagements.
• Trinity Partners: Boutique life sciences strategy consulting firm providing commercial strategy, market assessment, and analytics services to pharma and biotech. Highly comparable to HSP on customer base, service mix, and boutique positioning.
• Simon-Kucher & Partners: Global consulting firm with a sizable Life Sciences practice focused on pricing, market access, and commercial strategy. Overlaps with HSP on payer value demonstration, market access, and launch strategy work.
• Health Advances: Specialized healthcare strategy consulting firm focused on biopharma, medtech, and diagnostics, providing commercial diligence, forecasting, and portfolio strategy. Comparable to HSP on exclusivity, senior-led delivery, and biopharma strategy focus.

Broad incumbents

• IQVIA: The largest global life sciences and healthcare consulting, market research, and data analytics firm. Three of HSP's four senior leaders previously held executive roles at IQVIA, and IQVIA competes directly with HSP across commercial due diligence, brand strategy, launch, and value-demonstration engagements.
• McKinsey & Company: Global generalist consultancy with a sizable Pharma & Medical Products practice covering commercial due diligence, indication prioritization, and launch strategy. Ritesh Kumar held a leadership position in McKinsey's healthcare practice and overlaps with HSP on enterprise pharma strategy work.
• Bain & Company: Global generalist consultancy with a dedicated Healthcare and Life Sciences practice covering commercial strategy, M&A, and operations for pharma clients. Competes with HSP for enterprise pharma commercial strategy engagements.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hsp-healthcare-strategy-partners

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healthcare Strategy Partners (HSP)